TCG Crossover GP II, LLC - 30 Jan 2026 SCHEDULE 13G Report for ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share (ALXO)

Filing Manager
TCG Crossover GP II, LLC
Reporting Manager
Chen Yu
Security
ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share
Symbol
ALXO
Shares outstanding
131,432,818 shares
Disclosed Ownership
13,011,849 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
06 Feb 2026, 16:42:36 UTC
Date of event
30 Jan 2026
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TCG Crossover GP II, LLC 5% 6,505,925 0 6,505,925 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund II, L.P. 5% 6,505,925 0 6,505,925 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover GP III, LLC 5% 6,505,924 0 6,505,924 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund III, L.P. 5% 6,505,924 0 6,505,924 /s/ Craig Skaling Craig Skaling, Authorized Signatory
Chen Yu 9.9% 13,011,849 0 13,011,849 /s/ Craig Skaling Craig Skaling, as Attorney-in-Fact for Chen Yu